Coronary artery disease (CAD) risk factor analysis in an age-stratified hospital population with systemic lupus erythematosus (SLE).
Coronary artery disease
Lupus
Risk factors
SLE
Journal
International Journal of Cardiology. Hypertension
ISSN: 2590-0862
Titre abrégé: Int J Cardiol Hypertens
Pays: Netherlands
ID NLM: 101773659
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
12
09
2020
accepted:
09
10
2020
entrez:
15
1
2021
pubmed:
16
1
2021
medline:
16
1
2021
Statut:
epublish
Résumé
Patients with systemic lupus erythematosus (SLE) are at higher risk for coronary artery disease (CAD) particularly at a younger age. We sought to determine the effect of risk factors on the prevalence of CAD in age stratified hospitalized patients with SLE. The National Inpatient Sample (NIS) was queried for hospitalized patients with SLE during the years 2010-2015, and a control group without SLE. The study sample was stratified by age, 18-35 years, 36-55 years, and adults >55 years. The effect of SLE and traditional Framingham risk factors on the prevalence of CAD were assessed. Dominance analysis allowed for ranking of CAD risk factors in each age group. A total 167,466 patients were matched to an equal number of controls. 88.8% were women, 48.5% Caucasian and 29% African-American. In lupus patients 18-35 years prevalent risk factors included hyperlipidemia, hypertension, hypercoagulability and CKD. Diabetes and depression ranked least important. In middle and older patients, traditional risk factors were dominant. In adults >55 years the prevalence of CAD appears higher in Caucasians whereas in young patients 18-35 years, African Americans are dominant. CAD in the young adult patient with SLE is represented predominately by an African-American population and it is dominated by a hypercoagulable state and a less significant role for diabetes. In the lupus cohort over 55 years, which is predominantly Caucasian, SLE specific factors are less significant.
Identifiants
pubmed: 33447777
doi: 10.1016/j.ijchy.2020.100056
pii: S2590-0862(20)30033-1
pmc: PMC7803040
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100056Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
Authors have disclosed no conflicts of interest. Drs Levinson and Abugroun contributed equally to the manuscript. All authors had a role in writing the manuscript. All author takes responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Références
Int J Epidemiol. 2015 Dec;44(6):1800-13
pubmed: 26705418
Semin Arthritis Rheum. 2016 Apr;45(5):604-10
pubmed: 26711309
J Rheumatol. 2004 Apr;31(4):713-9
pubmed: 15088296
Arthritis Rheum. 2001 Oct;44(10):2331-7
pubmed: 11665973
J Rheumatol. 2017 Dec;44(12):1841-1849
pubmed: 29093154
Clin Rev Allergy Immunol. 2011 Feb;40(1):42-9
pubmed: 20063186
Ann Rheum Dis. 2015 Aug;74(8):1530-6
pubmed: 24692585
Rheumatology (Oxford). 2015 Jul;54(7):1244-9
pubmed: 25587177
Rheumatology (Oxford). 2018 Nov 1;57(11):1964-1971
pubmed: 30016488
JAMA. 2009 Apr 1;301(13):1341-8
pubmed: 19336709
Arthritis Rheumatol. 2020 Jun;72(6):972-984
pubmed: 31994323
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
J Rheumatol. 2014 Apr;41(4):680-7
pubmed: 24532834
Arthritis Rheum. 2010 Sep;62(9):2767-75
pubmed: 20506536
Eur Heart J. 2017 Nov 7;38(42):3119-3121
pubmed: 29121230
Neth J Med. 2017 Apr;75(3):99-105
pubmed: 28469051
Semin Arthritis Rheum. 2013 Aug;43(1):77-95
pubmed: 23422269
Arthritis Rheum. 2003 Sep;48(9):2519-23
pubmed: 13130471
Curr Cardiol Rev. 2013 Feb 1;9(1):15-9
pubmed: 23463953
Am J Epidemiol. 1997 Mar 1;145(5):408-15
pubmed: 9048514
Arthritis Rheumatol. 2019 Feb;71(2):290-301
pubmed: 30152151
Expert Opin Drug Saf. 2017 Mar;16(3):411-419
pubmed: 27927040
J Rheumatol. 2016 May;43(5):875-9
pubmed: 26879352
Immunol Res. 2017 Apr;65(2):543-550
pubmed: 28168401
Ann Rheum Dis. 2006 Sep;65(9):1168-74
pubmed: 16905579
J Immunol Res. 2014;2014:621270
pubmed: 25133195
BMJ Case Rep. 2009;2009:
pubmed: 21686697